Georgia's Online Cancer Information Center

Find A Treatment Site

Emory University Hospital - Atlanta

Emory University Hospital is a 587 bed facility specializing in the care of the acutely ill adult. Staffed exclusively by School of Medicine faculty who are also members of The Emory Clinic, the hospital is renowned as one of the nation's leaders in cardiology and cardiac surgery, oncology, transplantation and the neurosciences. The mission of Emory University Hospital is to provide excellence in patient care, enhanced by education and research. Emory University Hospital has established a solid foundation for outstanding quality health care, leadership and medical integrity and has been included in U. S. News and World Report's "America's Best Hospitals."

Treatment Sites in Georgia

Primary Location

1364 Clifton Road NE
Atlanta, GA 30322
404-712-2000 (p)
www.emoryhealthcare.org

driving directions

Doctors

Nazmi Volkan Adsay MD
Cletus A. Arciero MD
Bruce J. Barron MD
Deborah A. Baumgarten MD, MPH
Daniel J. Brat MD, PhD
Otis W. Brawley MD
Kenneth Cardona MD
Grant W. Carlson MD
Bradley C. Carthon, MD, PhD
Amy Y. Chen MD
Suephy C. Chen MD, MS
Cynthia Cohen MD
Ian R. Crocker MD, FACR
Walter J Curran, Jr. MD, FACR
Keith A. Delman MD, FACS
Roberto R. Diaz MD
Scott H. Edelman MD
John William Eley MD, MPH
Bassel F El-Rayes MD
Natia Esiashvili MD
Christopher R. Flowers MD
Lisa Flowers MD
Sheryl A. Gabram-Mendola MD, MBA, FACS
Anthony Andrew Gal MD
Jacques Galipeau MD
Karen D. Godette MD
Alan N. Gordon MD
Chunhai Hao MD, PhD
Wayne B. Harris MD
Natalyn N. Hawk MD
Leonard T. Heffner Jr., MD
Bruce W. Hershatter MD
Kristin Higgins MD
Charles E. Hill MD
Ira R. Horowitz MD, SM, FACOG, FACS
Stephen B. Hunter MD
Ashesh B. Jani MD
David L. Jaye MD
Cassandra Josephson MD
Jonathan L. Kaufman MD
Christine L. Kempton MD
Mohammad K Khan MD, PhD
Namita Khanna MD
H. Jean Khoury MD, FACP
David A. Kooby MD
Omer Kucuk MD
J. David Lambeth MD, PhD
Jerome C. Landry MD
Amelia A. Langston MD
Stephen K. Lau MD
Mary Jo Lechowicz MD
Melinda Moore Lewis MD
Shiyong Li MD, PhD
James V. Little MD
Sagar Lonial MD
Shishir K. Maithel MD
Karen P. Mann MD, PhD
Viraj Master MD, PhD
Morgan L. McLemore MD
Mario Mosunjac MD
Peter T. Nieh MD
Ajay K. Nooka MD, MPH
Kenneth Ogan MD
Jeffrey J. Olson MD
Thomas A. Olson MD
Gabriela M. Oprea MD
Suchita Pakkala MD
Douglas C. Parker MD
John G. Pattaras MD
Rathi Pillai MD
Suresh S. Ramalingam MD
William Read , MD
Satyanarayan K. Reddy MD
Maria J. Ribeiro MD
Monica Rizzo MD
Seth A Rosen MD
Peter J. Rossi MD
Maria Russell MD
Nabil F. Saba MD, FACP
Judy H. Sequeira MD
Charles W. Sewell MD
Walid L Shaib
Joseph Shelton MD
Dong Moon Shin MD
Momin T. Siddiqui MD, FIAC
Charles A. Staley MD
Liza J. Stapleford MD
Sidney F. Stein MD
Toncred M. Styblo MD
Talaat S. Tadros MD
Mylin A. Torres MD
Vijay Alluri Varma MD
Edmund K. Waller MD, PhD, FACP
Sharon W. Weiss MD
Ifor R. Williams MD, PhD
Joshua Winer MD
Elliott F. Winton MD

Clinical Trials in Georgia

A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With HCC
Cancer Type: Liver Cancer / Hepatoblastoma

A Phase 1 Study in Patients With HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma
Cancer Type: Head and Neck Cancer, Skin Cancer (Non-Melanoma), Unknown Primary

A Phase 1, Dose Escalation and Expansion Study of Engineered Donor Grafts Derived From Mobilized Peripheral Blood (OrcaGraft), With Single Agent Graft Versus-host Disease Prophylaxis, in Recipients Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies
Cancer Type: Myelodysplastic Syndromes (MDS)

A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL
Cancer Type: Leukemia

A Study of ABC294640 (Yeliva ®) Alone and in Combination With Hydroxychloroquine Sulfate in Treatment of Patients With Advanced Cholangiocarcinoma
Cancer Type: Bile Duct Cancer

A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
Cancer Type: Prostate Cancer , Unknown Primary

A Study of ASP1951 in Subjects With Advanced Solid Tumors
Cancer Type: Cervical Cancer, Colon/Rectal Cancer, Lung Cancer, Prostate Cancer

A Study of BI-1206 in Combination With Rituximab in Subjects With Indolent B-Cell Non-Hodgkin Lymphoma
Cancer Type: Hematopoietic Malignancies, Lymphoma, Non-Hodgkin Lymphoma, Unknown Primary

A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma
Cancer Type: Multiple Myeloma

A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations
Cancer Type: Solid Tumor, Unknown Primary

A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants
Cancer Type: Unknown Primary

A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors
Cancer Type: Anal Cancer, Gynecologic Cancers, Head and Neck Cancer, Lung Cancer, Mesothelioma, Penile Cancer, Skin Cancer (Non-Melanoma), Unknown Primary, Uterine Cancer

A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)
Cancer Type: Head and Neck Cancer

A Study to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Subjects With aGVHD
Cancer Type: Unknown Primary

An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)
Cancer Type: Lung Cancer

Atezolizumab in Treating Patients with Cancer following Adoptive Cell Transfer
Cancer Type: Hematopoietic Malignancies

Cabozantinib in Treating Patients with Locally Advanced Non-metastatic Kidney Cancer
Cancer Type: Kidney Cancer, Unknown Primary

Curcumin in Treating HIV Infected and Uninfected Women with High Grade Cervical Squamous Intraepithelial Neoplasia
Cancer Type: Unknown Primary

Denosumab in Treating Patients with Multiple Myeloma with Kidney Insufficiency
Cancer Type: Multiple Myeloma, Plasma cell neoplasm

Educational Interview in Improving Health Literacy in African-American Participants with Prostate Cancer
Cancer Type: Prostate Cancer , Unknown Primary

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)
Cancer Type: Bladder Cancer

Evaluation of Human Immune Responses to Vaccination in Patients with Lymphoma
Cancer Type: Hematopoietic Malignancies, Leukemia, Non-Hodgkin Lymphoma

Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML)
Cancer Type: Cancer-Related Syndrome, Leukemia, Myelodysplastic Syndromes (MDS)

Fluciclovine (18F) PET/CT Imaging in Indicating Early Metastatic Disease in Patients with High or Unfavorable Intermediate-Risk Prostate Cancer
Cancer Type: Prostate Cancer , Unknown Primary

Genistein in Preventing Cardiometabolic Dysfunction in Patients with Prostate Cancer Undergoing Androgen Deprivation Therapy
Cancer Type: Prostate Cancer

Hepatic Impairment Study for Lorlatinib in Cancer Patients
Cancer Type: Brain & Spinal Cord Tumor, Lymphoma

Image Guided Cryosurgery in Managing Post Mastectomy Pain Syndrome in Patients That Have Undergone Mastectomy, Partial Mastectomy, Lumpectomy, or Breast Reconstruction
Cancer Type: Breast Cancer, Unknown Primary

Immuno-Oncology Drugs Elotuzumab, Anti-LAG-3 and Anti-TIGIT
Cancer Type: Multiple Myeloma

Integrated Telehealth or In-Person Palliative Care in Improving Quality of Life in Patients with Advanced Non-small Cell Lung Cancer
Cancer Type: Lung Cancer, Unknown Primary

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Cancer Type: Breast Cancer

Ixazomib and Pevonedistat in Treating Patients with Multiple Myeloma That Has Come Back or Does Not Respond to Treatment
Cancer Type: Multiple Myeloma

Ketorolac before Surgery for the Treatment of Stage I-II Non-small Cell Lung Cancer or Stage III Renal Cell Cancer
Cancer Type: Lung Cancer

Low Dose Y90 Microspheres for the Planning of Radioembolization Therapy in Patients with Stage A-C Liver Cancer
Cancer Type: Liver Cancer / Hepatoblastoma, Unknown Primary

Mesenchymal Stem Cell Transplant in Treating Patients with Acute or Chronic Graft-Versus-Host Disease
Cancer Type: Unknown Primary

Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial
Cancer Type: Cancer-Related Syndrome, Unknown Primary

Myeloma-Developing Regimens Using Genomics (MyDRUG)
Cancer Type: Multiple Myeloma

Neihulizumab (AbGn-168H) in Patients With Steroid-refractory Acute Graft-versus-host Disease or Treatment-refractory Acute Graft-versus-host Disease
Cancer Type: Unknown Primary

Nelfinavir Mesylate in Treating Patients with Kaposi Sarcoma
Cancer Type: Sarcoma

Nivolumab and Lenalidomide in Treating Patients with Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma
Cancer Type: Hodgkin Lymphoma, Lymphoma, Non-Hodgkin Lymphoma

Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Cancer Type: Hematopoietic Malignancies, Lymphoma, Non-Hodgkin Lymphoma, Unknown Primary

Perflutren Lipid Microspheres Ultrasound in Diagnosing Patients with Intraocular Tumors Undergoing Diagnostic Surgery
Cancer Type: Eye Cancer, Melanoma

PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies
Cancer Type: Leukemia

Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors
Cancer Type: Solid Tumor, Unknown Primary

Proton Beam Radiation Therapy or Photon Beam Radiation Therapy in Treating Patients with Non-Metastatic Breast Cancer, A Radiotherapy Comparative Effectiveness (RadComp) Consortium Trial
Cancer Type: Breast Cancer

Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer
Cancer Type: Lung Cancer, Unknown Primary

Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
Cancer Type: Cancer-Related Syndrome, Leukemia, Myelodysplastic Syndromes (MDS)

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options
Cancer Type: Neuroblastoma

Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM)
Cancer Type: Multiple Myeloma

Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer with a High Chance of Recurring
Cancer Type: Prostate Cancer , Unknown Primary

The Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Graft-Versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell Transplant
Cancer Type: Cancer-Related Syndrome, Hematopoietic Malignancies, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes (MDS), Plasma cell neoplasm
**GeorgiaCancerInfo is not a medical practice. This is an informational web site provided by Georgia CORE, a nonprofit striving to provide current and comprehensive information on cancer care in Georgia through this website. If you find erroneous or missing information, please contact us.
Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofit that leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.